Product Program year 2023 Source: CMS Open Payments

VNS - Vitaria

Device Cardiology/Vascular Diseases

Open in the dashboard

General payments

$382,506

477 payments

Research payments

$4,947,986

1,083 payments

Through program year 2023, $382,506 in general payments and $4,947,986 in research payments were reported against VNS - Vitaria (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2023 General $67,911 95
2023 Research $1,114,087 228
2022 General $176,689 188
2022 Research $2,182,051 351
2021 General $137,906 194
2021 Research $1,651,847 504

Breakdown

Who paid General payments · program years 2021–2023
  1. LivaNova USA, Inc. $382,506 477 payments
Top recipients General payments · program year 2023
  1. Marvin Konstam Cardiovascular Disease · Boston, MA $15,125 22% · 3 payments
  2. Peter Carson Washington, DC $8,600 13% · 7 payments
  3. Richard Patten Advanced Heart Failure and Transplant Cardiology · Burlington, MA $6,280 9% · 7 payments
  4. Paul Hauptman Cardiovascular Disease · St Louis, MO $6,140 9% · 7 payments
  5. Ayan Patel Cardiovascular Disease · Boston, MA $5,280 8% · 8 payments

The top 5 of 26 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Cardiovascular Disease Internal Medicine $33,710 57% · 9 practitioners
  2. Advanced Heart Failure and Transplant Cardiology Internal Medicine $22,804 38% · 8 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $2,125 4% · 1 practitioner
  4. Internal Medicine $500 <1% · 1 practitioner
  5. Family Medicine $72 <1% · 2 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Massachusetts $27,685 41% · 4 recipients
  2. District of Columbia $8,619 13% · 2 recipients
  3. Missouri $6,692 10% · 3 recipients
  4. California $4,750 7% · 3 recipients
  5. Washington $4,460 7% · 1 recipient

The top 5 of 12 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

477 general · 1,083 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record